QualityStocksNewsBreaks Archives - Page 2 of 1620

FridayAug 28, 2026 2:03 pm

QualityStocksNewsBreaks – WhiteFiber, Inc. (NASDAQ: WYFI) Closes Upsized $310 Million Convertible Notes Offering

WhiteFiber (NASDAQ: WYFI) announced the closing of its previously announced upsized private placement of $310 million principal amount of 5% convertible senior notes due 2032, including the full exercise of the initial purchasers’ $40 million option. The company received approximately $298.5 million in net proceeds, using approximately $118.5 million for concurrent transactions that exchanged $198.15 million of existing convertible notes for cash and approximately 6.3 million ordinary shares. WhiteFiber expects to use the remaining proceeds primarily for data center expansion, including additional properties, facility construction, energy service agreements, GPU servers and potential acquisitions, partnerships and joint ventures, as well as working capital and general corporate purposes. The financing supports WhiteFiber plans to advance its…

FridayAug 28, 2026 1:59 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Advances Global Robotic Surgery Strategy with SSi Mantra Platform

SS Innovations International (NASDAQ: SSII) is expanding its presence in the growing global robotic surgery market through its proprietary SSi Mantra surgical robotics platform, with a strategy focused on advanced technology, affordability, physician training, and international expansion. The company reports that more than 200 SSi Mantra systems have been installed worldwide, supporting over 12,000 robotic procedures across more than 170 surgical indications, including more than 650 cardiac procedures and more than 170 telesurgeries. SS Innovations is also investing in physician education through its international robotics training program, while pursuing U.S. FDA clearance and European regulatory approvals. Looking ahead, the company is exploring applications involving artificial intelligence, advanced…

FridayAug 28, 2026 1:10 pm

QualityStocksNewsBreaks – U.S. Gold Corp. (NASDAQ: USAU) to Showcase Gold and Copper Portfolio at Moody Capital Conference

U.S. Gold Corp. (NASDAQ: USAU) will present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York on Sept. 9–10, 2026. Chairman Luke Norman is scheduled to present at 11:05 a.m. ET on Sept. 9 and will also hold in-person one-on-one meetings during the conference. The presentation will be webcast through the conference website. U.S. Gold Corp. is a U.S.-focused gold and copper exploration and development company with projects in Wyoming, Nevada, and Idaho. To view the full press release, visit https://ibn.fm/atfQx About U.S. Gold Corp. U.S. Gold Corp. is a publicly traded, U.S.-focused gold…

FridayAug 28, 2026 1:00 pm

QualityStocksNewsBreaks – M2i Global Inc. (MTWO) to Spotlight Critical Minerals Initiatives at Investor Conference

M2i Global (OTCQB: MTWO) will present at the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference on Sept. 9–10 at The Westin New York Grand Central. The company will highlight its work in domestic critical mineral recovery, recycling, processing, and repository development while connecting with investors in New York. Attendees interested in meeting with M2i are encouraged to reach out to schedule time. To view the full press release, visit https://ibn.fm/sx0I1 About M2i Global Inc. M2i Global develops and operates the midstream infrastructure that converts critical minerals into qualified, traceable material for American defense, industrial, and manufacturing buyers.…

FridayAug 28, 2026 9:20 am

QualityStocksNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Featured in NetworkNewsWire Editorial on Counter-Drone Defense

Wrap Technologies (NASDAQ: WRAP) announced its placement in a NetworkNewsWire editorial titled “The Overlooked Layer Where Counter-Drone Investment Dollars Are Now Heading.” The editorial examines the evolving counter-drone defense market and the growing importance of sensing technology alongside directed-energy interception. It highlights Wrap’s efforts to establish a position in this area through an exclusive U.S. and NATO license to physics-based sensing technology paired with laser directed-energy interception through an expanded partnership with Israeli firm Frenel Imaging. The technologies are part of WrapShield(TM), the company’s open architecture aimed at Department of War force protection, DHS border security, critical infrastructure and tactical law…

FridayAug 28, 2026 9:10 am

QualityStocksNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in NetworkNewsAudio on Building AI Economy Physical Backbone

AZIO AI Holdings (NASDAQ: AZIO) was featured in a NetworkNewsAudio Audio Press Release titled “Inside the Multibillion-Dollar Race to Build the AI Economy’s Physical Backbone.” The audio release examines the concept of deployed GPU clusters as long-term, revenue-generating infrastructure and highlights AZIO’s integrated approach spanning GPU and compute-system sales, energy-backed hosting infrastructure and company-operated computing workloads. The model is designed to enable AZIO to capture value from both computing equipment and the physical infrastructure supporting its productive use over time. To view the full press release, visit https://ibn.fm/5bqxv ABOUT AZIO AI HOLDINGS, INC. Azio AI Holdings, Inc. (Nasdaq: AZIO), formerly…

ThursdayAug 27, 2026 3:38 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS Therapy to Phase 2 Development

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is a biopharmaceutical company focused on advancing innovative therapies and technologies. The company was featured in a recent article that discussed its efforts to advance Lucid-MS, an oral investigational therapy designed to inhibit demyelination and protect myelin in people with multiple sclerosis, as MS drug development increasingly expands beyond controlling inflammation toward neuroprotection and myelin preservation. Preclinical studies demonstrated myelin preservation and functional recovery in animal models, while the company’s Phase 1 program generated safety and pharmacokinetic data supporting further development. The U.S.…

ThursdayAug 27, 2026 3:21 pm

QualityStocksNewsBreaks – Dune Oil Corp. (CSE: DUNE) (OTCQB: TRLEF) (FSE: Z621) Announces Leadership Appointments and Sets 2026 Annual General Meeting

Dune Oil (CSE: DUNE) (OTCQB: TRLEF) (FSE: Z621) announced several leadership appointments, including the appointment of President Scott Lower as CEO and Jordan Coleman as chief operating officer. Sean Stofer, who served as interim CEO during the company transition, will continue as chairman and a director. Dune also appointed Neil Maedel to its board, adding more than 45 years of capital-markets, investment-banking and international resource-sector experience. Dune also announced that its 2026 Annual General Meeting of Shareholders ("AGM") will be held Nov. 16, 2026. Shareholders will be asked to set the number of directors at six, elect directors for the ensuing year, appoint…

ThursdayAug 27, 2026 3:07 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Expands GelrinC Clinical and Commercial Pathways

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC cell-free cartilage repair implant along parallel U.S. clinical and European commercial tracks, with more than half of the 80-patient pivotal Phase III SAGE study enrolled and recruitment targeted for completion in the third quarter of 2026. The FDA-approved single-arm study uses a historical microfracture control dataset owned by Regentis, and the company reports that the first 40 enrolled patients closely match the historical control group in baseline characteristics. In Europe, where GelrinC already has CE Mark approval, Regentis is preparing for broader commercialization through surgeon training, an expanding network of Centers of Excellence…

ThursdayAug 27, 2026 2:29 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Marks Growth as Avenvi Expands Asset Base

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its strengthened position among OTC-listed companies through consistent financial growth, timely reporting, vertical integration, prudent capital allocation, and ownership of hard real estate assets. Revenue increased to $35.7 million in FY2026 from $33.1 million in FY2025 and $11.95 million in FY2024, while gross profit rose to $25.5 million from $24.3 million and $7.8 million. The company attributes this progress to strategic investments and acquisitions made without adding debt, particularly its purchase of Avenvi, a real estate company whose 13-property portfolio includes the Texas property housing ETST’s Mister Meds…

Site Search

Company Search

Category: QualityStocksNewsBreaks